A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease

The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method

(2015) W. Reinisch et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)

(2013) Walter Reinisch et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease

(2012) Rayko Evstatiev et al.   Clinical Gastroenterology and Hepatology

FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease

(2011) Rayko Evstatiev et al.   GASTROENTEROLOGY

Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis

(2011) Thomas W. Lee et al.   Journal of Crohns & Colitis

Rapid Recurrence of IBD-Associated Anemia and Iron Deficiency After Intravenous Iron Sucrose and Erythropoietin Treatment

(2009) Stefanie Kulnigg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement

(2009) Javier P. Gisbert et al.   INFLAMMATORY BOWEL DISEASES

Intravenous iron in inflammatory bowel disease

(2009) Manuel Muñoz et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Anemia and inflammatory bowel diseases

(2009) Fernando Gomollón et al.   WORLD JOURNAL OF GASTROENTEROLOGY

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial

(2008) Stefanie Kulnigg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY